MORPHIX-GRF (CJC 1295 without DAC) 2 mg x 5 Vials – Roger Pharma

Description

Roger Pharma MORPHIX-GRF (CJC 1295 without DAC) is a peptide formulation containing CJC-1295 without DAC (Modified GRF 1-29), a short-acting growth hormone-releasing hormone (GHRH) analogue widely studied for its ability to stimulate endogenous growth hormone release. It is commonly researched for its role in growth hormone regulation, recovery, body composition, and metabolic function.

Each pack contains 5 vials, with 2 mg of CJC-1295 without DAC (Modified GRF 1-29) per vial, providing a total peptide content of 10 mg. Roger Pharma MORPHIX-GRF is supplied in a lyophilized format and is intended for research applications involving peptide science, endocrinology, and growth hormone studies.

Key Features

• CJC-1295 without DAC (Modified GRF 1-29) peptide formulation
• 2 mg per vial
• 5 vials per pack
• Total peptide content: 10 mg
• Lyophilized peptide format
• Studied for growth hormone-releasing hormone pathways
• Short-acting research peptide

Contents

• Active Ingredient: CJC-1295 without DAC (Modified GRF 1-29) – 2 mg
• Quantity: 5 Vials